UCL in the media
US legal scholar Ronald Dworkin dies in UK aged 81
The American philosopher and constitutional law expert Professor Ronald Dworkin (UCL Laws) has died at the age of 81.
Balance between Work and Life Misunderstood
Dr Tomas Chamorro-Premuzic (UCL Clinical, Educational & Health Psychology) advocates the concept of work-life imbalance, examining the connection between workaholic stereotypes, careers and engagement.
CryoSat spots Arctic sea-ice loss in autumn
The dramatic recent decline in Arctic sea-ice cover is illustrated by new data from Europe's UCL-led CryoSat-2 mission.
Dangers in free access to research
"Publisher profits will continue to be high at the expense of the public purse," said Professor David Price (UCL Vice-Provost for Research).
Political Science at the Guardian: introducing our new bloggers
Jack Stilgoe (UCL Science & Technology Studies) is announced as a contributor to a new Science Policy blog.
Paxman 'bully' row
Jeremy Paxman was branded a "bully" over his treatment of Tom Tyszczuk Smith (UCL medical student) who answered a question incorrectly.
Mathematical modelling with Lisa Jardine
Professor Lisa Jardine (UCL Renaissance Studies) discusses how complex maths has broken free of the laboratory and now influences every aspect of our lives.
Why are beards back?
"You might argue that if you're sufficiently fit to grow an enormous and not-grey beard you are making a statement that you are sexually fit," says Professor Steve Jones (UCL Genetics, Evolution & Environment).
Public Participation in Research Back in Vogue with Ascent of "Citizen Science"
Researchers need to think of citizen science as simply "a different way of producing scientific knowledge," says Professor Muki Haklay (UCL Engineering).
Debbie Fund has raised over £1 million for Cervical Cancer
Debbie Fund, set up in memory of Debbie Phillips, has raised over £1 million. The money has gone towards two cervical cancer research projects at »Ê¼Ò»ªÈË, one deciphering the cancer's genetic code, the other creating antibody-based treatments. "This generation of new antibodies brings us a significant step closer to a new treatment for patients with cervical cancers," said Professor Kerry Chester (UCL Cancer Institute).